board approved

Nov
13

Receptors for SARS-CoV-2 Present in Wide Variety of Human Cells

When the COVID-19 virus enters the body of a human being, it generally divides itself into two different parts. This happens due to two protein structures called the TMPRSS2 and the ACE2 found in the human cells. The emergence of this new virus, lead us through a lot of debate on viral infections getting into […]

DETAIL
Nov
11

Remdesivir Shows Promise in Largest of Several Clinical Trials

Remdesivir is a drug produced by Gilead Sciences for helping in treating Ebola patients. This antiviral drug has even experimented in the US clinical trials on around 1,063 coronavirus patients. When a patient suffering from the dreaded COVID-19 disease is hospitalized, he/she takes an average of 15 odd days to completely recover. When the same […]

DETAIL
Nov
10

Moderna’s Coronavirus Vaccine Spurs Immune Response: Early Data

As of 18th May 2020, drug maker Moderna, who were developing the SARS-CoV-2 vaccine announced that a candidate coronavirus vaccine test is successful and it can safely generate a considerable amount of immunity against the COVID-19 virus. This data was completely based on phase 1 of their clinical trials of the vaccine. According to reports, […]

DETAIL